Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
Goldhirsch A, Gelber RD, Price KN, Castiglione M, Coates AS, Rudenstam CM, Collins J, Lindtner J, Hacking A, Marini G, et al.
Goldhirsch A, et al.
Lancet. 1994 Feb 12;343(8894):377-81. doi: 10.1016/s0140-6736(94)91221-1.
Lancet. 1994.
PMID: 7905550
Clinical Trial.